“This trial emphasizes the importance of germline and somatic testing in patients with metastatic prostate cancer at the time of diagnosis; homologous recombination repair mutations have been ...

On May 29, the American Society of Clinical Oncology (ASCO) issued a new position statement with recommendations to properly implement and regulate artificial intelligence (AI) in the prior ...

The Minnesota Society of Clinical Oncology (MSCO) is the recipient of the 2024 Jeffery C. Ward Affiliate Advocacy Award. The Association for Clinical Oncology presented the award during the State ...

In addition to gaining a global network of more than 50,000 peers, ASCO membership includes a range of benefits to enhance your career, practice, and research.

The nomination period for the upcoming ASCO Election is now closed. ASCO staff will review recommendations to confirm eligibility of submitted names. Following the eligibility check, the ASCO ...

Disclaimer This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information ...

SPARGO, Inc. is the only official registration and housing provider for ASCO Meetings and Symposia. Individuals unaffiliated with ASCO or SPARGO, Inc. may entice prospective attendees into registering ...

ASCO® Guidelines Assistant is an interactive AI tool developed by ASCO and Google Cloud. The tool allows oncologists to quickly search and use ASCO Guidelines through a simple, intuitive chat. Quickly ...

Disclaimer This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information ...

Who does this study affect? People with metastatic castration-sensitive prostate cancer (mCSPC) with alterations in the homologous recombination repair (HRR) genes What did this study find?* The phase ...